ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

DCPC Board Ok’s Grant Programs In Prevention, Public Education

October 30, 1992

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

Cooperative Groups Meet With NCI to Discuss Plan to use Rosenberg’s Regimen At Member Institutions

December 13, 1985

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984